Orion OYJ (OTCMKTS:ORINY) Shares Gap Up – Should You Buy?

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY)’s share price gapped up before the market opened on Friday. The stock had previously closed at $54.00, but opened at $58.05. Orion OYJ shares last traded at $58.05, with a volume of 318 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group upgraded Orion OYJ from a “hold” rating to a “strong-buy” rating in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

Orion OYJ Price Performance

The firm has a market cap of $16.39 billion, a price-to-earnings ratio of 21.42 and a beta of 0.07. The stock’s fifty day moving average price is $47.64 and its 200-day moving average price is $41.53. The company has a current ratio of 2.64, a quick ratio of 1.48 and a debt-to-equity ratio of 0.08.

Orion OYJ (OTCMKTS:ORINY) last announced its quarterly earnings results on Wednesday, October 28th. The company reported $0.68 earnings per share for the quarter. The business had revenue of $623.96 million during the quarter. Orion OYJ had a net margin of 30.25% and a return on equity of 54.09%.

About Orion OYJ

Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes prescription medicines, over-the-counter products, generic pharmaceuticals and active pharmaceutical ingredients.

The company focuses on several therapeutic areas, including central nervous system disorders, oncology, respiratory diseases, pain management and veterinary medicine. Orion is particularly recognized for treatments related to Parkinson’s disease, as well as its Easyhaler line of inhaled medicines for respiratory conditions.

Founded in Finland in 1917, Orion is headquartered in Espoo.